Our Research
The focus of our research is developing viral vector-based gene replacement strategies for the treatment of inherited ocular disease.
Meet Dr. Boye
Shannon Boye graduated with a Ph.D in Neuroscience from the University of Florida in 2006. She is now a tenured full Professor and Chief of the Division of Cellular and Molecular Therapy in the Department of Pediatrics at the University of Florida. The focus of her research is developing viral vector-based gene therapies for the treatment of inherited ocular disease.
Recent Lab News
Podcast: Using Gene Therapy to Help the Blind See
After decades of research, gene therapy is starting to work. Shannon Boye is a professor of cellular and molecular therapeutics at the University of…
Gene therapy restores vision in first-ever trial…
After the treatment, one patient saw her first star. Another saw snowflakes for the first time. Other patients were newly able to navigate outside of…
Atsena Therapeutics Receives FDA Designation for…
The company was created by ocular gene therapy pioneers Dr. Shannon Boye and Associate Scientist Sanford Boye, who also run the Shannon E. Boye…
